Collaboration - September 8, 2017
Danish Gubra collaborates with Boehringer Ingelheim
Boehringer Ingelheim and Gubra announce a collaboration and license agreement for the development of novel peptide compounds to treat obesity. The collaboration will bring together Gubra’s expertise in the design, synthesis, characterization and in in vivo testing of therapeutic peptides with Boehringer Ingelheim’s expertise in the development of innovative medicines for patients with cardiometabolic disease. It further […]
Collaboration - September 29, 2013
Gubra and Sanofi enter research collaboration
Gubra have announced the launch of a new research collaboration agreement with Sanofi focusing on the discovery of gut peptides. The new research program initiated between Gubra and Sanofi builds upon the established research consortium between Gubra, Gentofte Hospital and the University of Copenhagen partly funded by the Danish National Advanced Technology foundation. “We are […]